Yi Larson

Chief Financial Officer, Turning Point Therapeutics, Inc.

Companies

Olema Pharmaceuticals, Inc.Board member Apr 6, 2021 to now¹
RayzeBio, Inc.Board member Sep 14, 2023 to Feb 27, 2024²
LianBioChief financial officer Oct 29, 2021 to Mar 31, 2023³
Turning Point Therapeutics, Inc.Chief financial officer Aug 27, 2019 to Feb 10, 2021⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

LianBio LIANY325,901 shares⁵$16.6K at $0.05Mar 29, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 29, 2023Granted 325,901 shares of LianBio⁵

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROlema Pharmaceuticals, Inc., Board member
2
SEC EDGARRayzeBio, Inc., Board member
3
SEC EDGARLianBio, Chief financial officer
4
SEC EDGARTurning Point Therapeutics, Inc., Chief financial officer
5
SEC EDGARLianBio shares after the filing of Mar 29, 2023